Home » Newsletters » BioWorld Science

BioWorld Science

May 31, 2010

View Archived Issues

Preclinical studies support investigation of CEM-101 in COPD

TEI-3252 identified as bifunctional bronchodilator

LX-1031 alleviates disease symptoms in phase II trial in IBS

UFD1L gene SNP correlates with early-onset schizophrenia

Favorable data presented on riociguat in pulmonary hypertension

AM-206 improves symptoms of allergic rhinitis in vivo

Tranexamic acid tablets reduce menstrual blood loss in clinical trials

Galderma claims new melanocortin MC4 receptor antagonists

NeuroSearch claims new K(V)7 potassium channel activators

Organon claims new HCN channel-modulating analgesics

Shanghai Genomics claims new protein kinase inhibitors

Funxional Therapeutics raises funds for phase II FX-125L trials in inflammation

AstraZeneca reports developments for first quarter 2010

NICE issues recommendation for somatropin products, including Omnitrope

New phase II data disclosed on simplified Visonac procedure

CrystalGenomics merges with BexPharm

Advanced Life Sciences expands Restanza collaboration with U.S. government

Pfizer halts Inspra trial early after significant benefit is shown

Bionomics provides overview of clinical programs

Prolia obtains marketing authorization in E.U.

Vertex identifies new ABC transporter modulators

FDA committee recommends approval of tesamorelin

NewLink begins phase III HyperAcute-Pancreas immunotherapy trial

CSL Behring gains national marketing authorizations for Berinert

Two phase III Heplisav trials cleared to continue immunizations

FDA and EMA approve reanalysis of images from phase III RG-1068 trial

Short-acting anesthetic/sedative CNS-7056 enters phase IIb trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...